None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Patients with chronic lumbosacral unilateral radiating pain over 3 months 2) Patients with symptom-related unilateral 1-2 level lesions of the lumbosacral spine in radiologic examination (CT or MRI) 3) Patients screened for neuropathic pain by obtaining 4 points or more in DN4 questionnaire 4) Patients whose symptoms have not improved even after conservative treatment for more than 3 months 5) Patients with pain intensity of NRS 4 or higher 6) 20 = age <80 7) Patients who voluntarily agreed in writing to participate in this clinical trial
Exclusion criteria
Exclusion criteria: 1) Patients in acute phase with pain period less than 3 months 2) Patients whose pain intensity is less than 4 points or 10 points in NRS 3) When the axial pain is more severe than the radiating pain 4) Patients with progressive motor weakness or neurological findings 5) Those who are contraindicated in nerve block procedure, such as coagulopathy or infection 6) Patients with uncontrolled medical or psychiatric problems 7) Patients with side effects from local anesthetics, steroids, or contrast agents 8) Pregnant or lactating patients 9) Patients diagnosed with cancer and undergoing treatment 10) Patients with a history of surgery on the cervical spine 11) If the patient does not agree to participate in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| NRS (Numerical rating scale, 0 = no pain, 10 = unbearable pain) | — |
Secondary
| Measure | Time frame |
|---|---|
| NRS (Numerical rating scale, 0 = no pain, 10 = unbearable pain);ODI(0 – 50; 0 = no disability, 50 = complete disability);MQS (Medication quantification scale);PHQ-9 (patient health questionnaire-9);GPE (Global perceived effect, 1-7);Responder rate (0 – 100% of patients) | — |
Countries
Korea, Republic of
Contacts
Asan Medical Center